| Line Item | 2024-03-30 | Y/Y |
|---|---|---|
| Revenue | $1.56B | +6.2% |
| Cost of Revenue | $889.8M | +2.9% |
| Gross Profit | $670.5M | +10.9% |
| R&D Expense | $33.0M | +3.8% |
| SG&A Expense | $253.5M | +10.4% |
| Operating Income | $342.2M | +16.8% |
| Interest Expense | $78.7M | +2.6% |
| Pre-tax Income | $261.8M | +24.8% |
| Income Tax | $51.9M |
| Line Item | 2024-03-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.5M | -2.9% |
| Accounts Receivable | $255.2M | +6.5% |
| Inventory | $622.8M | +6.1% |
| Current Assets | $965.5M | +5.7% |
| Total Assets | $4.68B | -0.3% |
| Current Liabilities | $294.3M | -4.8% |
| Long-term Debt | $1.19B | -14.7% |
| Line Item | 2024-03-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $274.7M | +24.5% |
| Capital Expenditures | $33.2M | -21.0% |
| Investing Cash Flow | -$52.2M | -272.9% |
| Financing Cash Flow | -$223.5M | +30.8% |
| Free Cash Flow | $241.5M | +35.2% |
| +20.7% |
| Net Income | $209.9M | +25.9% |
| EPS (Basic) | $6.47 | +29.4% |
| EPS (Diluted) | $6.41 | +29.8% |
| Total Liabilities |
| $1.93B |
| -10.6% |
| Stockholders' Equity | $2.75B | +8.5% |